These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular insights into the Philadelphia translocation. Heisterkamp N, Groffen J. Hematol Pathol; 1991 Apr; 5(1):1-10. PubMed ID: 2050600 [Abstract] [Full Text] [Related]
6. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia]. Matolcsy A. Orv Hetil; 2004 Dec 26; 145(52):2603-9. PubMed ID: 15724695 [Abstract] [Full Text] [Related]
7. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products. Allen PB, Morgan GJ, Wiedemann LM. Baillieres Clin Haematol; 1992 Oct 26; 5(4):897-930. PubMed ID: 1308169 [Abstract] [Full Text] [Related]
8. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia. Ito Y, Shimamoto T, Kuriyama Y, Nakajima A, Sumi M, Watanabe Y, Beppu H, Ohtsubo K, Ohyashiki K. Leukemia; 2002 May 26; 16(5):951-2. PubMed ID: 11986960 [No Abstract] [Full Text] [Related]
10. Bcr: a negative regulator of the Bcr-Abl oncoprotein. Wu Y, Ma G, Lu D, Lin F, Xu HJ, Liu J, Arlinghaus RB. Oncogene; 1999 Aug 05; 18(31):4416-24. PubMed ID: 10442632 [Abstract] [Full Text] [Related]
11. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13. Koduru PR, Goh JC, Pergolizzi RG, Lichtman SM, Broome JD. Oncogene; 1993 Dec 05; 8(12):3239-47. PubMed ID: 8247527 [Abstract] [Full Text] [Related]
13. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Clarkson B, Strife A. Leukemia; 1993 Nov 05; 7(11):1683-721. PubMed ID: 8231240 [Abstract] [Full Text] [Related]
14. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells]. Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI. Tsitologiia; 2007 Nov 05; 49(10):889-900. PubMed ID: 18074781 [Abstract] [Full Text] [Related]
15. Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies. Warmuth M, Danhauser-Riedl S, Hallek M. Ann Hematol; 1999 Feb 05; 78(2):49-64. PubMed ID: 10089019 [Abstract] [Full Text] [Related]
16. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Campbell ML, Li W, Arlinghaus RB. Oncogene; 1990 May 05; 5(5):773-6. PubMed ID: 2140598 [Abstract] [Full Text] [Related]
17. Abl: the prototype of oncogenic fusion proteins. Saglio G, Cilloni D. Cell Mol Life Sci; 2004 Dec 05; 61(23):2897-911. PubMed ID: 15583852 [Abstract] [Full Text] [Related]